|
OMIM |
Link |
Information gain |
01 |
|
corpus callosum, agenesis of, with facial anomalies and robin sequence
|
[NCBI]
|
0.00179515
|
|
|
immunodeficiency with cleft lip/palate, cataract, hypopigmentation, and absent corpus callosum
|
[NCBI]
|
0.00172074
|
|
|
NLS
|
[NCBI]
|
0.0016109
|
|
|
AOS
|
[NCBI]
|
0.00139121
|
|
|
dandy-walker-like malformation with atrioventricular septal defect
|
[NCBI]
|
0.00136816
|
|
|
cleidocranial dysplasia with micrognathia, absent thumbs, and distal aphalangia
|
[NCBI]
|
0.00135754
|
|
|
apnea, obstructive sleep
|
[NCBI]
|
0.00134613
|
|
|
CJD
|
[NCBI]
|
0.0013034
|
|
|
opsismodysplasia
|
[NCBI]
|
0.00119455
|
|
|
microcephaly, hiatus hernia, and nephrotic syndrome
|
[NCBI]
|
0.000998576
|
|
|
RA
|
[NCBI]
|
0.000970384
|
|
|
short rib-polydactyly syndrome, type iii
|
[NCBI]
|
0.000872798
|
|
|
cardiomyopathy, fatal fetal, due to myocardial calcification
|
[NCBI]
|
0.000859246
|
|
|
cataract, congenital, with mental impairment and dentate gyrus atrophy
|
[NCBI]
|
0.000859246
|
|
|
MRX52
|
[NCBI]
|
0.000859246
|
|
|
myopathy, autophagic vacuolar, infantile-onset
|
[NCBI]
|
0.000859246
|
|
|
armfield x-linked mental retardation syndrome
|
[NCBI]
|
0.000859246
|
|
|
polyneuropathy, lethal neonatal, axonal sensorimotor, autosomal recessive
|
[NCBI]
|
0.000859246
|
|
|
DWS
|
[NCBI]
|
0.00077534
|
|
|
short rib-polydactyly syndrome, type ii
|
[NCBI]
|
0.000707556
|
|
|
RDT
|
[NCBI]
|
0.000675815
|
|
|
dysosteosclerosis
|
[NCBI]
|
0.000596173
|
|
|
natural killer cell deficiency, familial isolated
|
[NCBI]
|
0.000596173
|
|
|
nievergelt syndrome
|
[NCBI]
|
0.000596173
|
|
|
multiple mitochondrial dysfunctions syndrome
|
[NCBI]
|
0.000596173
|
|
|
necrotizing encephalopathy, acute, autosomal dominant
|
[NCBI]
|
0.000596173
|
|
|
mullerian derivatives, persistence of, with lymphangiectasia and postaxial polydactyly
|
[NCBI]
|
0.000596173
|
|
|
osteodysplasia, familial, anderson type
|
[NCBI]
|
0.000596173
|
|
|
RTD
|
[NCBI]
|
0.000549057
|
|
|
USH1E
|
[NCBI]
|
0.000498212
|
|
|
cranioectodermal dysplasia
|
[NCBI]
|
0.000498212
|
|
|
spondylometaphyseal dysplasia, sedaghatian type
|
[NCBI]
|
0.000498212
|
|
|
MHAC
|
[NCBI]
|
0.000498212
|
|
|
trichohepatoenteric syndrome
|
[NCBI]
|
0.000498212
|
|
|
adducted thumb-clubfoot syndrome
|
[NCBI]
|
0.000498212
|
|
|
cerebellar atrophy with progressive microcephaly
|
[NCBI]
|
0.000498212
|
|
|
hypoadrenocorticism, familial
|
[NCBI]
|
0.000498212
|
|
|
bulbar palsy, progressive, with sensorineural deafness
|
[NCBI]
|
0.000498212
|
|
|
BWCNS
|
[NCBI]
|
0.000435348
|
|
|
fibrochondrogenesis
|
[NCBI]
|
0.000435348
|
|
|
ichthyosis follicularis, atrichia, and photophobia syndrome
|
[NCBI]
|
0.000435348
|
|
|
sneddon syndrome
|
[NCBI]
|
0.000435348
|
|
|
myeloproliferative syndrome, transient
|
[NCBI]
|
0.000422719
|
|
|
FRNS
|
[NCBI]
|
0.000409829
|
|
|
CF
|
[NCBI]
|
0.000397187
|
|
|
USH2B
|
[NCBI]
|
0.000389153
|
|
|
splenic hypoplasia
|
[NCBI]
|
0.000389153
|
|
|
hemifacial microsomia with radial defects
|
[NCBI]
|
0.000389153
|
|
|
dysgnathia complex
|
[NCBI]
|
0.000352775
|
|
|
cataract and cardiomyopathy
|
[NCBI]
|
0.000352775
|
|
|
schinzel-giedion midface-retraction syndrome
|
[NCBI]
|
0.000352775
|
|
|
neutrophilic dermatosis, acute febrile
|
[NCBI]
|
0.000352775
|
|
|
visceral myopathy, familial, with external ophthalmoplegia
|
[NCBI]
|
0.000352775
|
|
|
peho syndrome
|
[NCBI]
|
0.000352775
|
|
|
carnitine palmitoyltransferase ii deficiency, lethal neonatal
|
[NCBI]
|
0.000345935
|
|
|
pena-shokeir syndrome, type i
|
[NCBI]
|
0.000333453
|
|
|
gaucher disease, perinatal lethal
|
[NCBI]
|
0.000331118
|
|
|
FFI
|
[NCBI]
|
0.000318224
|
|
|
MUC1
|
[NCBI]
|
0.000302117
|
|
|
renal hamartomas, nephroblastomatosis, and fetal gigantism
|
[NCBI]
|
0.000297606
|
|
|
short rib-polydactyly syndrome, type iv
|
[NCBI]
|
0.000275775
|
|
|
PTHLH
|
[NCBI]
|
0.000274411
|
|
|
SHFLD1
|
[NCBI]
|
0.00025662
|
|
|
mitochondrial complex i deficiency
|
[NCBI]
|
0.000247081
|
|
|
SLC25A20
|
[NCBI]
|
0.000242495
|
|
|
acroosteolysis with osteoporosis and changes in skull and mandible
|
[NCBI]
|
0.000239602
|
|
|
AD
|
[NCBI]
|
0.000225874
|
|
|
cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency
|
[NCBI]
|
0.000214301
|
|
|
spinal muscular atrophy, type i, with congenital bone fractures
|
[NCBI]
|
0.000214301
|
|
|
SLOS
|
[NCBI]
|
0.000213811
|
|
|
megacystis-microcolon-intestinal hypoperistalsis syndrome
|
[NCBI]
|
0.000210518
|
|
|
mesothelioma, malignant
|
[NCBI]
|
0.000210518
|
|
|
AFP
|
[NCBI]
|
0.00020962
|
|
|
serpentine fibula-polycystic kidney syndrome
|
[NCBI]
|
0.000198583
|
|
|
abcd syndrome
|
[NCBI]
|
0.000187535
|
|
|
atpaf2 deficiency
|
[NCBI]
|
0.000187535
|
|
|
glycogen storage disease iv
|
[NCBI]
|
0.000186766
|
|
|
CRC
|
[NCBI]
|
0.000175615
|
|
|
long-chain 3-hydroxyacyl-coa dehydrogenase deficiency
|
[NCBI]
|
0.000169552
|
|
|
DGS
|
[NCBI]
|
0.000165703
|
|
|
EFE
|
[NCBI]
|
0.000162263
|
|
|
MBS
|
[NCBI]
|
0.000156858
|
|
|
proteus syndrome
|
[NCBI]
|
0.000156858
|
|
|
muscular dystrophy, congenital, with severe central nervous system atrophy and absence of large myelinated fibers
|
[NCBI]
|
0.000149464
|
|
|
CEACAM5
|
[NCBI]
|
0.000141132
|
|
|
alpers diffuse degeneration of cerebral gray matter with hepatic cirrhosis
|
[NCBI]
|
0.00013766
|
|
|
MG
|
[NCBI]
|
0.000132526
|
|
|
dubowitz syndrome
|
[NCBI]
|
0.000126062
|
|
|
diaphragmatic hernia, congenital
|
[NCBI]
|
0.000126062
|
|
|
MVA
|
[NCBI]
|
0.000125239
|
|
|
GACI
|
[NCBI]
|
0.000125239
|
|
|
ABS
|
[NCBI]
|
0.000121656
|
|
|
VWM
|
[NCBI]
|
0.000118297
|
|
|
SDS
|
[NCBI]
|
0.000117705
|
|
|
amyloidosis vii
|
[NCBI]
|
0.000111766
|
|
|
temporal arteritis
|
[NCBI]
|
0.000107775
|
|
|
megalencephaly-cutis marmorata telangiectatica congenita
|
[NCBI]
|
0.000104564
|
|
|
hemochromatosis, neonatal
|
[NCBI]
|
0.000104564
|
|
|
vacterl association with hydrocephalus, x-linked
|
[NCBI]
|
9.85239e-05
|
|
|
panencephalitis, subacute sclerosing
|
[NCBI]
|
9.84243e-05
|
|
|
CDLS1
|
[NCBI]
|
9.51502e-05
|
|
|
arthrogryposis with hyperkeratosis
|
[NCBI]
|
9.37525e-05
|
|
|
lethal short-limb skeletal dysplasia, al gazali type
|
[NCBI]
|
9.37525e-05
|
|
|
glutamine deficiency, congenital
|
[NCBI]
|
9.37525e-05
|
|
|
muscular dystrophy, congenital, megaconial type
|
[NCBI]
|
9.37525e-05
|
|
|
bifid nose, renal agenesis, and anorectal malformations
|
[NCBI]
|
9.37525e-05
|
|
|
PMSE
|
[NCBI]
|
9.37525e-05
|
|
|
intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies
|
[NCBI]
|
9.37525e-05
|
|
|
encephalopathy, fatal infantile, with olivopontocerebellar hypoplasia
|
[NCBI]
|
9.37525e-05
|
|
|
epidermolysis bullosa, lethal acantholytic
|
[NCBI]
|
9.37525e-05
|
|
|
spondyloepimetaphyseal dysplasia, x-linked, with mental deterioration
|
[NCBI]
|
9.37525e-05
|
|
|
COFS4
|
[NCBI]
|
9.37525e-05
|
|
|
arthropathy, tendinous calcinosis, and progeroid features
|
[NCBI]
|
9.37525e-05
|
|
|
motor neuron disease with dementia and ophthalmoplegia
|
[NCBI]
|
9.37525e-05
|
|
|
hydrocephalus, endocardial fibroelastosis, and cataracts
|
[NCBI]
|
9.37525e-05
|
|
|
pancreatic hypoplasia, congenital, with diabetes mellitus and congenital heart disease
|
[NCBI]
|
9.37525e-05
|
|
|
nephropathy, progressive tubulointerstitial, with cholestatic liver disease
|
[NCBI]
|
9.37525e-05
|
|
|
osteosclerotic chondrodysplasia, lethal, with intracellular inclusions
|
[NCBI]
|
9.37525e-05
|
|
|
meacham syndrome
|
[NCBI]
|
9.37525e-05
|
|
|
acrocephalopolydactylous dysplasia
|
[NCBI]
|
9.37525e-05
|
|
|
brachyphalangy, polydactyly, and tibial aplasia/hypoplasia
|
[NCBI]
|
9.37525e-05
|
|
|
atherosclerosis, premature, with deafness, nephropathy, diabetes mellitus, photomyoclonus, and degenerative neurologic disease
|
[NCBI]
|
9.37525e-05
|
|
|
ulnar hypoplasia with mental retardation
|
[NCBI]
|
9.37525e-05
|
|
|
hemolytic anemia, lethal congenital nonspherocytic, with genital and other abnormalities
|
[NCBI]
|
9.37525e-05
|
|
|
COXPD5
|
[NCBI]
|
9.37525e-05
|
|
|
CDG2B
|
[NCBI]
|
9.37525e-05
|
|
|
trisomy 18-like syndrome
|
[NCBI]
|
9.37525e-05
|
|
|
skeletal dysplasia and progressive central nervous system degeneration, lethal
|
[NCBI]
|
9.37525e-05
|
|
|
baby rattle pelvis dysplasia
|
[NCBI]
|
9.37525e-05
|
|
|
diarrhea 4, malabsorptive, congenital
|
[NCBI]
|
9.37525e-05
|
|
|
RNS
|
[NCBI]
|
9.33275e-05
|
|
|
c syndrome
|
[NCBI]
|
9.33275e-05
|
|
|
HSD17B4
|
[NCBI]
|
9.27385e-05
|
|
|
GIST
|
[NCBI]
|
8.74342e-05
|
|
|
holoprosencephaly
|
[NCBI]
|
8.71853e-05
|
|
|
EGF
|
[NCBI]
|
8.6804e-05
|
|
|
costello syndrome
|
[NCBI]
|
8.55246e-05
|
|
|
PCD
|
[NCBI]
|
8.27384e-05
|
|
|
PRNP
|
[NCBI]
|
8.25552e-05
|
|
|
hemangioma-thrombocytopenia syndrome
|
[NCBI]
|
8.10772e-05
|
|
|
SPS
|
[NCBI]
|
7.85119e-05
|
|
|
d-bifunctional protein deficiency
|
[NCBI]
|
7.77683e-05
|
|
|
GBE1
|
[NCBI]
|
7.67776e-05
|
|
|
KSS
|
[NCBI]
|
7.60429e-05
|
|
|
CMTC
|
[NCBI]
|
7.19522e-05
|
|
|
danon disease
|
[NCBI]
|
7.19522e-05
|
|
|
kabuki syndrome
|
[NCBI]
|
7.06643e-05
|
|
|
LMNA
|
[NCBI]
|
7.02176e-05
|
|
|
EIF2B5
|
[NCBI]
|
6.98859e-05
|
|
|
ALK
|
[NCBI]
|
6.65838e-05
|
|
|
SLE
|
[NCBI]
|
6.61704e-05
|
|
|
human herpesvirus type 6, integrated
|
[NCBI]
|
6.61653e-05
|
|
|
craniomicromelic syndrome
|
[NCBI]
|
6.61653e-05
|
|
|
glycogen storage disease of heart, lethal congenital
|
[NCBI]
|
6.61653e-05
|
|
|
biliary malformation with renal tubular insufficiency
|
[NCBI]
|
6.61653e-05
|
|
|
AGS4
|
[NCBI]
|
6.61653e-05
|
|
|
pulmonary hypoplasia, primary
|
[NCBI]
|
6.61653e-05
|
|
|
pyridoxamine 5-prime-phosphate oxidase deficiency
|
[NCBI]
|
6.61653e-05
|
|
|
radial aplasia, x-linked
|
[NCBI]
|
6.61653e-05
|
|
|
myelocytic leukemia-like syndrome, familial, chronic
|
[NCBI]
|
6.61653e-05
|
|
|
enterocolitis
|
[NCBI]
|
6.61653e-05
|
|
|
renal dysplasia, diffuse cystic
|
[NCBI]
|
6.61653e-05
|
|
|
MRX45
|
[NCBI]
|
6.61653e-05
|
|
|
malignant hyperthermia, susceptibility to, 5
|
[NCBI]
|
6.61653e-05
|
|
|
cleft lip/palate with characteristic facies, intestinal malrotation, and lethal congenital heart disease
|
[NCBI]
|
6.61653e-05
|
|
|
neuronal intranuclear inclusion disease
|
[NCBI]
|
6.61653e-05
|
|
|
asplenia with cystic liver, kidney, and pancreas
|
[NCBI]
|
6.61653e-05
|
|
|
lissencephaly type iii and bone dysplasia
|
[NCBI]
|
6.61653e-05
|
|
|
omphalocele, diaphragmatic hernia, and radial ray defects
|
[NCBI]
|
6.61653e-05
|
|
|
HADHA
|
[NCBI]
|
6.29284e-05
|
|
|
MHS1
|
[NCBI]
|
6.27385e-05
|
|
|
RP
|
[NCBI]
|
6.14675e-05
|
|
|
DA2A
|
[NCBI]
|
6.06326e-05
|
|
|
epidermolysis bullosa letalis
|
[NCBI]
|
6.06326e-05
|
|
|
EBR1
|
[NCBI]
|
5.8762e-05
|
|
|
DBA
|
[NCBI]
|
5.85088e-05
|
|
|
fraser syndrome
|
[NCBI]
|
5.6992e-05
|
|
|
epidermolysis bullosa with pyloric atresia
|
[NCBI]
|
5.6992e-05
|
|
|
tracheoesophageal fistula with or without esophageal atresia
|
[NCBI]
|
5.58689e-05
|
|
|
crisponi syndrome
|
[NCBI]
|
5.58689e-05
|
|
|
pulmonary hypertension, familial persistent, of the newborn
|
[NCBI]
|
5.58689e-05
|
|
|
MCOPCB3
|
[NCBI]
|
5.58689e-05
|
|
|
bile acid synthesis defect, congenital, 2
|
[NCBI]
|
5.58689e-05
|
|
|
agonadism with multiple internal malformations
|
[NCBI]
|
5.58689e-05
|
|
|
frank-ter haar syndrome
|
[NCBI]
|
5.53622e-05
|
|
|
PD
|
[NCBI]
|
5.19833e-05
|
|
|
SVAS
|
[NCBI]
|
5.1683e-05
|
|
|
epidermolysis bullosa simplex, ogna type
|
[NCBI]
|
4.92479e-05
|
|
|
nuchal bleb, familial
|
[NCBI]
|
4.92479e-05
|
|
|
myelocerebellar disorder
|
[NCBI]
|
4.92479e-05
|
|
|
cryohydrocytosis, stomatin-deficient, with mental retardation, seizures, cataracts, and massive hepatosplenomegaly
|
[NCBI]
|
4.92479e-05
|
|
|
simpson-golabi-behmel syndrome, type 2
|
[NCBI]
|
4.92479e-05
|
|
|
USH1F
|
[NCBI]
|
4.92479e-05
|
|
|
MLASA
|
[NCBI]
|
4.92479e-05
|
|
|
femur-fibula-ulna syndrome
|
[NCBI]
|
4.92479e-05
|
|
|
menkes disease
|
[NCBI]
|
4.7841e-05
|
|
|
AVSD
|
[NCBI]
|
4.71165e-05
|
|
|
klippel-trenaunay-weber syndrome
|
[NCBI]
|
4.579e-05
|
|
|
SCO2
|
[NCBI]
|
4.56642e-05
|
|
|
oculocerebrocutaneous syndrome
|
[NCBI]
|
4.43725e-05
|
|
|
NEM1
|
[NCBI]
|
4.43725e-05
|
|
|
lymphedema, hereditary, ii
|
[NCBI]
|
4.43725e-05
|
|
|
pseudodiastrophic dysplasia
|
[NCBI]
|
4.43725e-05
|
|
|
MRX54
|
[NCBI]
|
4.43725e-05
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-positive
|
[NCBI]
|
4.43725e-05
|
|
|
LISX2
|
[NCBI]
|
4.43725e-05
|
|
|
schneckenbecken dysplasia
|
[NCBI]
|
4.43725e-05
|
|
|
SGBS1
|
[NCBI]
|
4.32433e-05
|
|
|
PRKAG2
|
[NCBI]
|
4.2262e-05
|
|
|
mitochondrial complex iv deficiency
|
[NCBI]
|
4.21572e-05
|
|
|
HRAS
|
[NCBI]
|
4.19232e-05
|
|
|
l-2-hydroxyglutaric aciduria
|
[NCBI]
|
4.05251e-05
|
|
|
choreoathetosis, hypothyroidism, and neonatal respiratory distress
|
[NCBI]
|
4.05251e-05
|
|
|
whistling face syndrome, recessive form
|
[NCBI]
|
4.05251e-05
|
|
|
paget disease, juvenile
|
[NCBI]
|
4.05251e-05
|
|
|
gaucher disease, atypical, due to saposin c deficiency
|
[NCBI]
|
4.05251e-05
|
|
|
PLSDT
|
[NCBI]
|
4.05251e-05
|
|
|
lactic acidosis, fatal infantile
|
[NCBI]
|
4.05251e-05
|
|
|
naxos disease
|
[NCBI]
|
4.05251e-05
|
|
|
boomerang dysplasia
|
[NCBI]
|
4.05251e-05
|
|
|
MRXSL
|
[NCBI]
|
4.05251e-05
|
|
|
oeis complex
|
[NCBI]
|
4.05251e-05
|
|
|
USH2C
|
[NCBI]
|
4.05251e-05
|
|
|
XLP1
|
[NCBI]
|
4.01003e-05
|
|
|
LS
|
[NCBI]
|
3.99645e-05
|
|
|
PSEN1
|
[NCBI]
|
3.97571e-05
|
|
|
ARSA
|
[NCBI]
|
3.84095e-05
|
|
|
radial ray deficiency, x-linked
|
[NCBI]
|
3.76684e-05
|
|
|
cardiomyopathy, dilated, with woolly hair and keratoderma
|
[NCBI]
|
3.73571e-05
|
|
|
congenital disorder of glycosylation, type i/iix
|
[NCBI]
|
3.73571e-05
|
|
|
vacterl association with hydrocephalus
|
[NCBI]
|
3.73571e-05
|
|
|
cardiomyopathy, familial hypertrophic, with wolff-parkinson-white syndrome
|
[NCBI]
|
3.73571e-05
|
|
|
FHL2
|
[NCBI]
|
3.73571e-05
|
|
|
palmoplantar hyperkeratosis with squamous cell carcinoma of skin and sex reversal
|
[NCBI]
|
3.73571e-05
|
|
|
SQT1
|
[NCBI]
|
3.73571e-05
|
|
|
mucolipidosis ii
|
[NCBI]
|
3.72709e-05
|
|
|
ASS
|
[NCBI]
|
3.62946e-05
|
|
|
DHCR7
|
[NCBI]
|
3.62594e-05
|
|
|
FLT3
|
[NCBI]
|
3.5689e-05
|
|
|
GBA
|
[NCBI]
|
3.53329e-05
|
|
|
HPS2
|
[NCBI]
|
3.46719e-05
|
|
|
MRX9
|
[NCBI]
|
3.46719e-05
|
|
|
SCA8
|
[NCBI]
|
3.46719e-05
|
|
|
epiphyseal dysplasia, multiple, with early-onset diabetes mellitus
|
[NCBI]
|
3.46719e-05
|
|
|
myoclonic epilepsy, neonatal, with suppression-burst pattern
|
[NCBI]
|
3.46719e-05
|
|
|
GFAP
|
[NCBI]
|
3.25729e-05
|
|
|
fructose-1,6-bisphosphatase deficiency
|
[NCBI]
|
3.23478e-05
|
|
|
caffey disease
|
[NCBI]
|
3.23478e-05
|
|
|
ACG2
|
[NCBI]
|
3.23478e-05
|
|
|
por deficiency
|
[NCBI]
|
3.23478e-05
|
|
|
immunoosseous dysplasia, schimke type
|
[NCBI]
|
3.23478e-05
|
|
|
NSHPT
|
[NCBI]
|
3.23478e-05
|
|
|
IFNGR1
|
[NCBI]
|
3.23378e-05
|
|
|
ARX
|
[NCBI]
|
3.19307e-05
|
|
|
GCDH
|
[NCBI]
|
3.1158e-05
|
|
|
ACPP
|
[NCBI]
|
3.06586e-05
|
|
|
MTND5
|
[NCBI]
|
3.04349e-05
|
|
|
schwannomatosis
|
[NCBI]
|
3.03038e-05
|
|
|
trifunctional protein deficiency
|
[NCBI]
|
3.03038e-05
|
|
|
pseudotrisomy 13 syndrome
|
[NCBI]
|
3.03038e-05
|
|
|
LGMD2E
|
[NCBI]
|
3.03038e-05
|
|
|
USH1D
|
[NCBI]
|
3.03038e-05
|
|
|
renal tubular acidosis, distal, with progressive nerve deafness
|
[NCBI]
|
3.03038e-05
|
|
|
PCS
|
[NCBI]
|
3.03038e-05
|
|
|
stuve-wiedemann syndrome
|
[NCBI]
|
3.03038e-05
|
|
|
FMD
|
[NCBI]
|
3.03038e-05
|
|
|
CYBB
|
[NCBI]
|
3.00902e-05
|
|
|
ATPAF2
|
[NCBI]
|
2.94314e-05
|
|
|
MIPOL1
|
[NCBI]
|
2.94314e-05
|
|
|
SUCLG1
|
[NCBI]
|
2.94314e-05
|
|
|
ste20-related adaptor protein
|
[NCBI]
|
2.94314e-05
|
|
|
NF2
|
[NCBI]
|
2.88916e-05
|
|
|
ACADS
|
[NCBI]
|
2.88086e-05
|
|
|
3-@methylcrotonyl-coa carboxylase 1 deficiency
|
[NCBI]
|
2.84838e-05
|
|
|
hydrolethalus syndrome 1
|
[NCBI]
|
2.84838e-05
|
|
|
MCOPS3
|
[NCBI]
|
2.84838e-05
|
|
|
kniest dysplasia
|
[NCBI]
|
2.84838e-05
|
|
|
EDNRB
|
[NCBI]
|
2.82193e-05
|
|
|
NPY
|
[NCBI]
|
2.75242e-05
|
|
|
VEGF
|
[NCBI]
|
2.68489e-05
|
|
|
mitochondrial dna depletion syndrome, myopathic form
|
[NCBI]
|
2.68467e-05
|
|
|
plasminogen deficiency, type i
|
[NCBI]
|
2.68467e-05
|
|
|
tight skin contracture syndrome, lethal
|
[NCBI]
|
2.68467e-05
|
|
|
carbamoyl phosphate synthetase i deficiency, hyperammonemia due to
|
[NCBI]
|
2.68467e-05
|
|
|
encephalopathy, neonatal severe, due to mecp2 mutations
|
[NCBI]
|
2.68467e-05
|
|
|
HHS
|
[NCBI]
|
2.68467e-05
|
|
|
SMDP1
|
[NCBI]
|
2.68467e-05
|
|
|
FA
|
[NCBI]
|
2.65465e-05
|
|
|
MTATP6
|
[NCBI]
|
2.6374e-05
|
|
|
GMPS
|
[NCBI]
|
2.6329e-05
|
|
|
MRPS22
|
[NCBI]
|
2.6329e-05
|
|
|
SLC35D1
|
[NCBI]
|
2.6329e-05
|
|
|
CEP1
|
[NCBI]
|
2.6329e-05
|
|
|
GAS7
|
[NCBI]
|
2.6329e-05
|
|
|
MLL
|
[NCBI]
|
2.56693e-05
|
|
|
wolff-parkinson-white syndrome
|
[NCBI]
|
2.53619e-05
|
|
|
epidermolysis bullosa simplex and limb-girdle muscular dystrophy
|
[NCBI]
|
2.53619e-05
|
|
|
USH3
|
[NCBI]
|
2.53619e-05
|
|
|
pearson marrow-pancreas syndrome
|
[NCBI]
|
2.53619e-05
|
|
|
XPD
|
[NCBI]
|
2.53619e-05
|
|
|
DSG3
|
[NCBI]
|
2.52237e-05
|
|
|
OTC
|
[NCBI]
|
2.4384e-05
|
|
|
PNPO
|
[NCBI]
|
2.4318e-05
|
|
|
NDUFS3
|
[NCBI]
|
2.4318e-05
|
|
|
LPP
|
[NCBI]
|
2.4318e-05
|
|
|
RNASEH2A
|
[NCBI]
|
2.4318e-05
|
|
|
ZNF81
|
[NCBI]
|
2.4318e-05
|
|
|
MAP3K3
|
[NCBI]
|
2.4318e-05
|
|
|
GCS1
|
[NCBI]
|
2.4318e-05
|
|
|
amyotrophic lateral sclerosis-parkinsonism/dementia complex 1
|
[NCBI]
|
2.4006e-05
|
|
|
tetralogy of fallot
|
[NCBI]
|
2.4006e-05
|
|
|
AGS1
|
[NCBI]
|
2.4006e-05
|
|
|
OPD2
|
[NCBI]
|
2.4006e-05
|
|
|
LGMD1B
|
[NCBI]
|
2.4006e-05
|
|
|
JBS
|
[NCBI]
|
2.4006e-05
|
|
|
USH1C
|
[NCBI]
|
2.4006e-05
|
|
|
KCNQ1
|
[NCBI]
|
2.34191e-05
|
|
|
TRIM21
|
[NCBI]
|
2.28253e-05
|
|
|
NDUFV2
|
[NCBI]
|
2.28253e-05
|
|
|
PUS1
|
[NCBI]
|
2.28253e-05
|
|
|
MTTW
|
[NCBI]
|
2.28253e-05
|
|
|
GFM1
|
[NCBI]
|
2.28253e-05
|
|
|
CTHM
|
[NCBI]
|
2.27605e-05
|
|
|
waardenburg-shah syndrome
|
[NCBI]
|
2.27605e-05
|
|
|
muckle-wells syndrome
|
[NCBI]
|
2.27605e-05
|
|
|
ALD
|
[NCBI]
|
2.25051e-05
|
|
|
thrombocytopenic purpura, autoimmune
|
[NCBI]
|
2.20359e-05
|
|
|
TD1
|
[NCBI]
|
2.17125e-05
|
|
|
FTSJ1
|
[NCBI]
|
2.16379e-05
|
|
|
ATP6V1B1
|
[NCBI]
|
2.16379e-05
|
|
|
NDUFS1
|
[NCBI]
|
2.16379e-05
|
|
|
GCE
|
[NCBI]
|
2.16107e-05
|
|
|
NBIA1
|
[NCBI]
|
2.16107e-05
|
|
|
PFM
|
[NCBI]
|
2.16107e-05
|
|
|
alexander disease
|
[NCBI]
|
2.16107e-05
|
|
|
IPEX
|
[NCBI]
|
2.16107e-05
|
|
|
infantile sialic acid storage disorder
|
[NCBI]
|
2.16107e-05
|
|
|
IVA
|
[NCBI]
|
2.16107e-05
|
|
|
ACHE
|
[NCBI]
|
2.0834e-05
|
|
|
LPI
|
[NCBI]
|
2.07929e-05
|
|
|
RYR1
|
[NCBI]
|
2.06733e-05
|
|
|
OPTB3
|
[NCBI]
|
2.05444e-05
|
|
|
molybdenum cofactor deficiency
|
[NCBI]
|
2.05444e-05
|
|
|
FXTAS
|
[NCBI]
|
2.05444e-05
|
|
|
TH
|
[NCBI]
|
2.01109e-05
|
|
|
NDUFS4
|
[NCBI]
|
1.98101e-05
|
|
|
NIPBL
|
[NCBI]
|
1.98101e-05
|
|
|
FANCE
|
[NCBI]
|
1.98101e-05
|
|
|
PEX6
|
[NCBI]
|
1.98101e-05
|
|
|
BGS
|
[NCBI]
|
1.9552e-05
|
|
|
HPS
|
[NCBI]
|
1.90784e-05
|
|
|
ARSE
|
[NCBI]
|
1.9075e-05
|
|
|
TK2
|
[NCBI]
|
1.9075e-05
|
|
|
POR
|
[NCBI]
|
1.9075e-05
|
|
|
CD3D
|
[NCBI]
|
1.9075e-05
|
|
|
NEUROG3
|
[NCBI]
|
1.9075e-05
|
|
|
CRLF1
|
[NCBI]
|
1.9075e-05
|
|
|
CHX10
|
[NCBI]
|
1.9075e-05
|
|
|
KLK3
|
[NCBI]
|
1.89875e-05
|
|
|
BWS
|
[NCBI]
|
1.87663e-05
|
|
|
acyl-coa dehydrogenase, very long-chain, deficiency of
|
[NCBI]
|
1.86252e-05
|
|
|
PCLD
|
[NCBI]
|
1.86252e-05
|
|
|
TTDP
|
[NCBI]
|
1.86252e-05
|
|
|
AMPH
|
[NCBI]
|
1.84232e-05
|
|
|
farber lipogranulomatosis
|
[NCBI]
|
1.84232e-05
|
|
|
polycystic kidneys
|
[NCBI]
|
1.813e-05
|
|
|
FGFR3
|
[NCBI]
|
1.80815e-05
|
|
|
AIRE
|
[NCBI]
|
1.78414e-05
|
|
|
SGCB
|
[NCBI]
|
1.78378e-05
|
|
|
NAGS
|
[NCBI]
|
1.78378e-05
|
|
|
canavan disease
|
[NCBI]
|
1.7757e-05
|
|
|
refsum disease, infantile form
|
[NCBI]
|
1.7757e-05
|
|
|
KRT20
|
[NCBI]
|
1.75248e-05
|
|
|
ECGF1
|
[NCBI]
|
1.73068e-05
|
|
|
GLUL
|
[NCBI]
|
1.73068e-05
|
|
|
EIF2AK3
|
[NCBI]
|
1.73068e-05
|
|
|
SUZ12
|
[NCBI]
|
1.73068e-05
|
|
|
CDPX1
|
[NCBI]
|
1.69416e-05
|
|
|
MNGIE
|
[NCBI]
|
1.69416e-05
|
|
|
ZNF198
|
[NCBI]
|
1.6821e-05
|
|
|
MSN
|
[NCBI]
|
1.6821e-05
|
|
|
HLCS
|
[NCBI]
|
1.63735e-05
|
|
|
TCIRG1
|
[NCBI]
|
1.63735e-05
|
|
|
CSF2RB
|
[NCBI]
|
1.63735e-05
|
|
|
NPM1
|
[NCBI]
|
1.58154e-05
|
|
|
AP3B1
|
[NCBI]
|
1.55725e-05
|
|
|
glycogen storage disease iii
|
[NCBI]
|
1.54498e-05
|
|
|
USH2A
|
[NCBI]
|
1.54498e-05
|
|
|
MADD
|
[NCBI]
|
1.54498e-05
|
|
|
THBD
|
[NCBI]
|
1.5211e-05
|
|
|
SOX2
|
[NCBI]
|
1.48714e-05
|
|
|
AMFR
|
[NCBI]
|
1.48714e-05
|
|
|
RMD
|
[NCBI]
|
1.47652e-05
|
|
|
acyl-coa dehydrogenase, medium-chain, deficiency of
|
[NCBI]
|
1.47652e-05
|
|
|
SCDO1
|
[NCBI]
|
1.47652e-05
|
|
|
FGFR1
|
[NCBI]
|
1.4748e-05
|
|
|
ADSL
|
[NCBI]
|
1.45513e-05
|
|
|
ITGB4
|
[NCBI]
|
1.45513e-05
|
|
|
TPM3
|
[NCBI]
|
1.45513e-05
|
|
|
ACTA1
|
[NCBI]
|
1.45513e-05
|
|
|
JMML
|
[NCBI]
|
1.43927e-05
|
|
|
wilson disease
|
[NCBI]
|
1.43927e-05
|
|
|
DNM1L
|
[NCBI]
|
1.42486e-05
|
|
|
lymphoma, non-hodgkin, familial
|
[NCBI]
|
1.42402e-05
|
|
|
NEM3
|
[NCBI]
|
1.4117e-05
|
|
|
PBD
|
[NCBI]
|
1.4117e-05
|
|
|
AHC
|
[NCBI]
|
1.4117e-05
|
|
|
ehlers-danlos syndrome, type iv, autosomal dominant
|
[NCBI]
|
1.4117e-05
|
|
|
SEDC
|
[NCBI]
|
1.4117e-05
|
|
|
VIP
|
[NCBI]
|
1.39767e-05
|
|
|
CA2
|
[NCBI]
|
1.39616e-05
|
|
|
PHOX2B
|
[NCBI]
|
1.39616e-05
|
|
|
CACNA1S
|
[NCBI]
|
1.39616e-05
|
|
|
SFTPB
|
[NCBI]
|
1.39616e-05
|
|
|
CPT2
|
[NCBI]
|
1.36887e-05
|
|
|
DSP
|
[NCBI]
|
1.36887e-05
|
|
|
SMA2
|
[NCBI]
|
1.35022e-05
|
|
|
atypical mycobacteriosis, familial
|
[NCBI]
|
1.35022e-05
|
|
|
ALMS
|
[NCBI]
|
1.35022e-05
|
|
|
ERCC1
|
[NCBI]
|
1.34288e-05
|
|
|
MC2R
|
[NCBI]
|
1.34288e-05
|
|
|
EBP
|
[NCBI]
|
1.34288e-05
|
|
|
LAMB3
|
[NCBI]
|
1.31806e-05
|
|
|
NKX2-1
|
[NCBI]
|
1.31806e-05
|
|
|
LTC4S
|
[NCBI]
|
1.31806e-05
|
|
|
PMM2
|
[NCBI]
|
1.29433e-05
|
|
|
mucopolysaccharidosis type vii
|
[NCBI]
|
1.29182e-05
|
|
|
OPTB1
|
[NCBI]
|
1.29182e-05
|
|
|
FTD
|
[NCBI]
|
1.25695e-05
|
|
|
PMS2
|
[NCBI]
|
1.24975e-05
|
|
|
myoclonic epilepsy of lafora
|
[NCBI]
|
1.23628e-05
|
|
|
PHS
|
[NCBI]
|
1.23628e-05
|
|
|
usher syndrome, type i
|
[NCBI]
|
1.23628e-05
|
|
|
MVK
|
[NCBI]
|
1.22877e-05
|
|
|
apc gene
|
[NCBI]
|
1.21403e-05
|
|
|
PITX2
|
[NCBI]
|
1.18912e-05
|
|
|
pyruvate decarboxylase deficiency
|
[NCBI]
|
1.18339e-05
|
|
|
alzheimer disease 3
|
[NCBI]
|
1.18339e-05
|
|
|
leiomyomatosis and renal cell cancer, hereditary
|
[NCBI]
|
1.18339e-05
|
|
|
APC
|
[NCBI]
|
1.17387e-05
|
|
|
ETV6
|
[NCBI]
|
1.17034e-05
|
|
|
CYP11B2
|
[NCBI]
|
1.1522e-05
|
|
|
EDN3
|
[NCBI]
|
1.1522e-05
|
|
|
GPC3
|
[NCBI]
|
1.1522e-05
|
|
|
ERCC2
|
[NCBI]
|
1.13467e-05
|
|
|
neuraminidase deficiency with beta-galactosidase deficiency
|
[NCBI]
|
1.13467e-05
|
|
|
MCOPS7
|
[NCBI]
|
1.13297e-05
|
|
|
MTND6
|
[NCBI]
|
1.11769e-05
|
|
|
WHS
|
[NCBI]
|
1.10323e-05
|
|
|
HMI
|
[NCBI]
|
1.10125e-05
|
|
|
EGFR
|
[NCBI]
|
1.0854e-05
|
|
|
anemia, sideroblastic, x-linked
|
[NCBI]
|
1.08531e-05
|
|
|
RBS
|
[NCBI]
|
1.08486e-05
|
|
|
MTCO2
|
[NCBI]
|
1.06984e-05
|
|
|
APOE
|
[NCBI]
|
1.06694e-05
|
|
|
MYO7A
|
[NCBI]
|
1.05482e-05
|
|
|
ASPA
|
[NCBI]
|
1.04022e-05
|
|
|
ATP7A
|
[NCBI]
|
1.04022e-05
|
|
|
PTPRC
|
[NCBI]
|
1.02602e-05
|
|
|
wolman disease
|
[NCBI]
|
1.02602e-05
|
|
|
DSG1
|
[NCBI]
|
1.0122e-05
|
|
|
TTR
|
[NCBI]
|
1.0113e-05
|
|
|
TNFRSF1B
|
[NCBI]
|
9.98749e-06
|
|
|
GRN
|
[NCBI]
|
9.98749e-06
|
|
|
PARK2
|
[NCBI]
|
9.94961e-06
|
|
|
JAK2
|
[NCBI]
|
9.70581e-06
|
|
|
KCNH2
|
[NCBI]
|
9.70581e-06
|
|
|
CVID
|
[NCBI]
|
9.5785e-06
|
|
|
POLG
|
[NCBI]
|
9.48235e-06
|
|
|
SOX9
|
[NCBI]
|
9.48235e-06
|
|
|
SRS
|
[NCBI]
|
9.34898e-06
|
|
|
TNF
|
[NCBI]
|
9.17163e-06
|
|
|
ABCA1
|
[NCBI]
|
9.13421e-06
|
|
|
SJS1
|
[NCBI]
|
9.12668e-06
|
|
|
CDPX2
|
[NCBI]
|
9.12668e-06
|
|
|
CLL
|
[NCBI]
|
9.12668e-06
|
|
|
campomelic dysplasia
|
[NCBI]
|
9.12668e-06
|
|
|
COL3A1
|
[NCBI]
|
8.91496e-06
|
|
|
WAS
|
[NCBI]
|
8.91496e-06
|
|
|
FGF23
|
[NCBI]
|
8.91496e-06
|
|
|
RTT
|
[NCBI]
|
8.86598e-06
|
|
|
factor vii deficiency
|
[NCBI]
|
8.80889e-06
|
|
|
leber optic atrophy
|
[NCBI]
|
8.80305e-06
|
|
|
SMA3
|
[NCBI]
|
8.741e-06
|
|
|
MDLS
|
[NCBI]
|
8.741e-06
|
|
|
SH2D1A
|
[NCBI]
|
8.70505e-06
|
|
|
MTND1
|
[NCBI]
|
8.60338e-06
|
|
|
PSAP
|
[NCBI]
|
8.60338e-06
|
|
|
FLNA
|
[NCBI]
|
8.50378e-06
|
|
|
PROCR
|
[NCBI]
|
8.40619e-06
|
|
|
ITGB2
|
[NCBI]
|
8.40619e-06
|
|
|
CDG1A
|
[NCBI]
|
8.37122e-06
|
|
|
MYH7
|
[NCBI]
|
8.31053e-06
|
|
|
KIT
|
[NCBI]
|
8.31053e-06
|
|
|
MPO
|
[NCBI]
|
8.0983e-06
|
|
|
aHUS
|
[NCBI]
|
8.0165e-06
|
|
|
MJD
|
[NCBI]
|
7.94083e-06
|
|
|
WT1
|
[NCBI]
|
7.77359e-06
|
|
|
WAS
|
[NCBI]
|
7.74318e-06
|
|
|
LPL
|
[NCBI]
|
7.72119e-06
|
|
|
NF2
|
[NCBI]
|
7.68974e-06
|
|
|
UGT1A1
|
[NCBI]
|
7.52641e-06
|
|
|
PWS
|
[NCBI]
|
7.52165e-06
|
|
|
EV
|
[NCBI]
|
7.23266e-06
|
|
|
CFTR
|
[NCBI]
|
7.0731e-06
|
|
|
CDSP
|
[NCBI]
|
7.03499e-06
|
|
|
LOX
|
[NCBI]
|
6.8557e-06
|
|
|
LRRK2
|
[NCBI]
|
6.78696e-06
|
|
|
adrenoleukodystrophy, autosomal neonatal form
|
[NCBI]
|
6.73312e-06
|
|
|
FGA
|
[NCBI]
|
6.71926e-06
|
|
|
APOA1
|
[NCBI]
|
6.58689e-06
|
|
|
MTTL1
|
[NCBI]
|
6.45839e-06
|
|
|
RTS
|
[NCBI]
|
6.44289e-06
|
|
|
MTHFR
|
[NCBI]
|
6.21222e-06
|
|
|
dystrophia myotonica 1
|
[NCBI]
|
6.18376e-06
|
|
|
ADA
|
[NCBI]
|
6.16536e-06
|
|
|
aortic valve disease
|
[NCBI]
|
5.89522e-06
|
|
|
BTK
|
[NCBI]
|
5.81283e-06
|
|
|
AR
|
[NCBI]
|
5.61198e-06
|
|
|
antithrombin iii deficiency
|
[NCBI]
|
5.60062e-06
|
|
|
LAM
|
[NCBI]
|
5.4677e-06
|
|
|
PCD
|
[NCBI]
|
5.4677e-06
|
|
|
CSA
|
[NCBI]
|
5.38807e-06
|
|
|
LNS
|
[NCBI]
|
5.14861e-06
|
|
|
GUSB
|
[NCBI]
|
5.02347e-06
|
|
|
HHT
|
[NCBI]
|
4.91804e-06
|
|
|
sickle cell anemia
|
[NCBI]
|
4.91804e-06
|
|
|
BL
|
[NCBI]
|
4.82727e-06
|
|
|
PC
|
[NCBI]
|
4.80594e-06
|
|
|
IFNA1
|
[NCBI]
|
4.76388e-06
|
|
|
AMC
|
[NCBI]
|
4.69599e-06
|
|
|
OCP
|
[NCBI]
|
4.69599e-06
|
|
|
F3
|
[NCBI]
|
4.64132e-06
|
|
|
RNASE2
|
[NCBI]
|
4.52093e-06
|
|
|
CLS
|
[NCBI]
|
4.48212e-06
|
|
|
ARPKD
|
[NCBI]
|
4.27611e-06
|
|
|
SPINK1
|
[NCBI]
|
4.25638e-06
|
|
|
CPI
|
[NCBI]
|
4.14938e-06
|
|
|
ED1
|
[NCBI]
|
4.07766e-06
|
|
|
NPC1
|
[NCBI]
|
3.70231e-06
|
|
|
SLS
|
[NCBI]
|
3.70231e-06
|
|
|
NGFR
|
[NCBI]
|
3.39134e-06
|
|
|
PTEN
|
[NCBI]
|
3.30796e-06
|
|
|
ACADM
|
[NCBI]
|
3.07061e-06
|
|
|
PCNA
|
[NCBI]
|
2.83283e-06
|
|
|
PTH
|
[NCBI]
|
2.59321e-06
|
|
|
HGPS
|
[NCBI]
|
2.58943e-06
|
|
|
G6PD
|
[NCBI]
|
2.5677e-06
|
|
|
AVP
|
[NCBI]
|
2.54511e-06
|
|
|
velocardiofacial syndrome
|
[NCBI]
|
2.32202e-06
|
|
|
TS
|
[NCBI]
|
2.25959e-06
|
|
|
metachromatic leukodystrophy
|
[NCBI]
|
2.19585e-06
|
|
|
WBS
|
[NCBI]
|
2.01099e-06
|
|
|
glycogen storage disease ii
|
[NCBI]
|
1.95783e-06
|
|
|
PJS
|
[NCBI]
|
1.94752e-06
|
|
|
PLG
|
[NCBI]
|
1.74304e-06
|
|
|
RB1
|
[NCBI]
|
1.64146e-06
|
|
|
SCA2
|
[NCBI]
|
1.43988e-06
|
|
|
DFSP
|
[NCBI]
|
1.43422e-06
|
|
|
CCD
|
[NCBI]
|
1.26098e-06
|
|
|
NF1
|
[NCBI]
|
1.25994e-06
|
|
|
CHS
|
[NCBI]
|
1.24886e-06
|
|
|
DRPLA
|
[NCBI]
|
1.19621e-06
|
|
|
SOD1
|
[NCBI]
|
1.18211e-06
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-negative, due to adenosine deaminase deficiency
|
[NCBI]
|
8.77003e-07
|
|
|
PXE
|
[NCBI]
|
8.08911e-07
|
|
|
SPP1
|
[NCBI]
|
8.08773e-07
|
|
|
RNASE3
|
[NCBI]
|
8.08039e-07
|
|
|
MBP
|
[NCBI]
|
7.15511e-07
|
|
|
MBL2
|
[NCBI]
|
6.74701e-07
|
|
|
LCAT
|
[NCBI]
|
6.46372e-07
|
|
|
PMD
|
[NCBI]
|
5.23264e-07
|
|
|
TNFRSF11B
|
[NCBI]
|
4.04752e-07
|
|
|
TSD
|
[NCBI]
|
3.84034e-07
|
|
|
HSCR1
|
[NCBI]
|
3.52733e-07
|
|
|
ZS
|
[NCBI]
|
3.44118e-07
|
|
|
APS1
|
[NCBI]
|
3.44118e-07
|
|
|
GHRH
|
[NCBI]
|
3.24671e-07
|
|
|
amyloidosis vi
|
[NCBI]
|
3.10002e-07
|
|
|
TNFSF6
|
[NCBI]
|
2.67752e-07
|
|
|
PGR
|
[NCBI]
|
2.46938e-07
|
|
|
FRAP1
|
[NCBI]
|
2.20673e-07
|
|
|
CD
|
[NCBI]
|
2.06279e-07
|
|
|
FMF
|
[NCBI]
|
1.94375e-07
|
|
|
ABCC1
|
[NCBI]
|
1.57766e-07
|
|
|
krabbe disease
|
[NCBI]
|
1.51637e-07
|
|
|
EPO
|
[NCBI]
|
1.33483e-07
|
|
|
BBS
|
[NCBI]
|
7.24183e-08
|
|
|
VHL
|
[NCBI]
|
5.35504e-08
|
|
|
HD
|
[NCBI]
|
5.24137e-08
|
|
|
MFS
|
[NCBI]
|
2.54985e-08
|
|
|
CMH
|
[NCBI]
|
1.18378e-08
|
|
|
TFPI
|
[NCBI]
|
1.09476e-08
|
|
|
hla-d histocompatibility type
|
[NCBI]
|
2.28571e-09
|
|